Circulating levels of the adipokine chemerin in gestational diabetes mellitus

Hormone Research in Paediatrics

Volumn 74, Issue 1, 2010, Pages 56-61

  Pfau, Dörte ^a   Stepan, Holger ^b   Kratzsch, Jürgen ^a   Verlohren, Michael ^c   Verlohren, Hans Joachim ^c   Drynda, Kathrin ^c   Lössner, Ulrike ^a   Blüher, Matthias ^a   Stumvoll, Michael ^a   Fasshauer, Mathias ^a  

^a UNIVERSITY OF LEIPZIG   (Germany)

^b Department of Obstetrics ^*  (Germany)

^c Outpatient Care Unit   (Germany)

Author keywords

Adipokine; Chemerin; Gestational diabetes; Insulin resistance; Obesity

Indexed keywords

ADIPOCYTOKINE; CHEMERIN; CREATININE; INSULIN; UNCLASSIFIED DRUG;

ADULT; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; CORRELATION ANALYSIS; CREATININE BLOOD LEVEL; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; GESTATIONAL AGE; GLUCOSE METABOLISM; HOMEOSTASIS; HUMAN; INFLAMMATION; INSULIN RESISTANCE; KIDNEY DYSFUNCTION; KIDNEY FUNCTION; LIPID METABOLISM; MULTIVARIATE ANALYSIS; PREGNANCY; PREGNANCY DIABETES MELLITUS; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; UNIVARIATE ANALYSIS;

ADULT; C-REACTIVE PROTEIN; CHEMOKINES; CHOLESTEROL; CREATININE; DIABETES, GESTATIONAL; FEMALE; GESTATIONAL AGE; HUMANS; INSULIN; INSULIN RESISTANCE; PREGNANCY; STATISTICS, NONPARAMETRIC; TRIGLYCERIDES;

EID: 77954795110     PISSN: 16632818     EISSN: 16632826     Source Type: Journal    
DOI: 10.1159/000282114     Document Type: Article

References (24)

1. Buchanan TA, Xiang A, Kjos SL, Watanabe R: What is gestational diabetes? Diabetes Care 2007;30(suppl 2):S105-S111.
2. Lobner K, Knopff A, Baumgarten A, Mollenhauer U, Marienfeld S, Garrido-Franco M, Bonifacio E, Ziegler AG: Predictors of postpartum diabetes in women with gestational diabetes mellitus. Diabetes 2006;55:792-797.
3. Bo S, Valpreda S, Menato G, Bardelli C, Botto C, Gambino R, Rabbia C, Durazzo M, Cassader M, Massobrio M, Pagano G: Should we consider gestational diabetes a vascular risk factor? Atherosclerosis 2007;194:e72-e79.
4. Ranheim T, Haugen F, Staff AC, Braekke K, Harsem NK, Drevon CA: Adiponectin is reduced in gestational diabetes mellitus in normal weight women. Acta Obstet Gynecol Scand 2004;83:341-347.
5. Ategbo JM, Grissa O, Yessoufou A, Hichami A, Dramane KL, Moutairou K, Miled A, Grissa A, Jerbi M, Tabka Z, Khan NA: Modulation of adipokines and cytokines in gestational diabetes and macrosomia. J Clin Endocrinol Metab 2006;91:4137-4143.
6. Kinalski M, Telejko B, Kuzmicki M, Kretowski A, Kinalska I: Tumor necrosis factor-a system and plasma adiponectin concentration in women with gestational diabetes. Horm Metab Res 2005;37:450-454.
7. Lain KY, Daftary AR, Ness RB, Roberts JM: First trimester adipocytokine concentrations and risk of developing gestational diabetes later in pregnancy. Clin Endocrinol (Oxf) 2008;69:407-411.
8. Retnakaran R, Hanley AJ, Raif N, Hirning CR, Connelly PW, Sermer M, Kahn SE, Zinman B: Adiponectin and β-cell dysfunction in gestational diabetes: pathophysiological implications. Diabetologia 2005; 48:9931001.
9. Qiu C, Williams MA, Vadachkoria S, Frederick IO, Luthy DA: Increased maternal plasma leptin in early pregnancy and risk of gestational diabetes mellitus. Obstet Gynecol 2004;103:519-525. (Pubitemid 40459068)
10. Maghbooli Z, Hossein-Nezhad A, Rahmani M, Shafaei AR, Larijani B: Relationship between leptin concentration and insulin resistance. Horm Metab Res 2007;39:903-907.
11. Kralisch S, Stepan H, Kratzsch J, Verlohren M, Verlohren HJ, Drynda K, Lossner U, Bluher M, Stumvoll M, Fasshauer M: Serum levels of adipocyte fatty acid binding protein are increased in gestational diabetes mellitus. Eur J Endocrinol 2009; 160:33-38.
12. Bozaoglu K, Bolton K, McMillan J, Zimmet P, Jowett J, Collier G, Walder K, Segal D: Chemerin is a novel adipokine associated with obesity and metabolic syndrome. Endocrinology 2007;148:4687-4694.
13. Goralski KB, McCarthy TC, Hanniman EA, Zabel BA, Butcher EC, Parlee SD, Muruganandan S, Sinal CJ: Chemerin, a novel adipokine that regulates adipogenesis and adipocyte metabolism. J Biol Chem 2007; 282: 28175-28188.
14. Roh SG, Song SH, Choi KC, Katoh K, Wittamer V, Parmentier M, Sasaki S: Chemerin - a new adipokine that modulates adipogenesis via its own receptor. Biochem Biophys Res Commun 2007;362:1013-1018.
15. Takahashi M, Takahashi Y, Takahashi K, Zolotaryov FN, Hong KS, Kitazawa R, Iida K, Okimura Y, Kaji H, Kitazawa S, Kasuga M, Chihara K: Chemerin enhances insulin signaling and potentiates insulin-stimulated glucose uptake in 3T3-L1 adipocytes. FEBS Lett 2008;582:573-578.
16. Kautzky-Willer A, Bancher-Todesca D, Weitgasser R, Prikoszovich T, Steiner H, Shnawa N, Schernthaner G, Birnbacher R, Schneider B, Marth C, Roden M, Lechleitner M: The impact of risk factors and more stringent diagnostic criteria of gestational diabetes on outcomes in central European women. J Clin Endocrinol Metab 2008;93:1689-1695.
17. Matthews DR, Hosker JP, Rudenski AS, Naylor BA, Treacher DF, Turner RC: Homeostasis model assessment: insulin resistance and β-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia 1985;28:412-419.
18. Zhang Y, Scarpace PJ: The role of leptin in leptin resistance and obesity. Physiol Behav 2006; 88:249-256.
19. Pfau D, Bachmann A, Lössner U, Kratzsch J, Bluher M, Stumvoll M, Fasshauer M: Serum levels of the adipokine chemerin in relation to renal function. Diabetes Care 2010; 33: 171-173.
20. Zoccali C, Mallamaci F, Tripepi G, Benedetto FA, Cutrupi S, Parlongo S, Malatino LS, Bonanno G, Seminara G, Rapisarda F, Fatuzzo P, Buemi M, Nicocia G, Tanaka S, Ouchi N, Kihara S, Funahashi T, Matsuzawa Y: Adiponectin, metabolic risk factors, and cardiovascular events among patients with end-stage renal disease. J Am Soc Nephrol 2002;13:134-141. (Pubitemid 34042020)
21. Merabet E, Dagogo-Jack S, Coyne DW, Klein S, Santiago JV, Hmiel SP, Landt M: Increased plasma leptin concentration in end-stage renal disease. J Clin Endocrinol Metab 1997; 82: 847-850.
22. Ziegelmeier M, Bachmann A, Seeger J, Lössner U, Kratzsch J, Blüher M, Stumvoll M, Fasshauer M: Serum levels of the adipokine RBP-4 in relation to renal function. Diabetes Care 2007;30:2588-2592.
23. Sommer G, Ziegelmeier M, Bachmann A, Kralisch S, Lössner U, Kratzsch J, Blüher M, Stumvoll M, Fasshauer M: Serum levels of adipocyte fatty acid binding protein are increased in chronic haemodialysis. Clin Endocrinol (Oxf) 2008;69:901-905.
24. Stein S, Bachmann A, Lössner U, Kratzsch J, Bluher M, Stumvoll M, Fasshauer M: Serum levels of the adipokine FGF21 depend on renal function. Diabetes Care 2009; 32: 126128.